Kinin B1 receptor expression on multiple sclerosis mononuclear cells: Correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability

Archives of Neurology

Volumn 62, Issue 5, 2005, Pages 795-800

  Prat, Alexandre ^a,c   Biernacki, Katarzyna ^a   Saroli, Tanya ^a   Orav, John E ^b   Guttmann, Charles R G ^b   Weiner, Howard L ^b   Khoury, Samia J ^b   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BRADYKININ B1 RECEPTOR; KININ; MESSENGER RNA; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; DISABILITY; GENE; GENE EXPRESSION; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; MONOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; STATISTICS; TIME;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DISABILITY EVALUATION; FEMALE; GENE EXPRESSION; GENES, MHC CLASS II; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; RECEPTOR, BRADYKININ B1; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS; TIME FACTORS;

EID: 18544374882     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.5.795     Document Type: Article

References (13)

1. Marceau F. Kinin B1 receptor: a review. Immunopharmacology. 1995;30:1-26.
2. Marceau F, Hess JF, Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev. 1998;50:357-386.
3. Hall JM. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992;56:131-190.
4. Drummond GR, Cocks TM. Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery. Br J Pharmacol. 1995;116:2473-2481.
5. Smith JA, Webb C, Holford J, Burgess GM. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol Pharmacol. 1995;47:525-534.
6. Sardi SP, Daray FM, Errasti AE, et al. Further pharmacological characterization of bradykinin B1 receptor up-regulation in human umbilical vein. J Pharmacol Exp Ther. 1999;290:1019-1025.
7. Sardi SP, Ares VR, Errasti AE, Rothlin RP. Bradykinin B1 receptors in human umbilical vein: pharmacological evidence of up-regulation, and induction by interleukin-1 beta. Eur J Pharmacol. 1998;358:221-227.
8. Prat A, Weinrib L, Becher B, et al. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology, 1999;53:2087-2092.
9. deBlois D, Bouthillier J, Marceau F. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1. Br J Pharmacol. 1991;103:1057-1066.
10. Germain L, Barabe J, Galeano CJ. Increased blood concentration of des-arg9 bradykinin in experimental allergic encephalomyelitis. J Neurol Sci. 1988;83:211-217.
11. Weiner HL, Khoury SJ, Guttmann CR, et al. Magnetic resonance imaging correlates with clinical disability and attacks in multiple sclerosis. Neurology. 1998;50:A322-A323.
12. Khoury SJ, Orav EJ, Guttmann CR, Kikinis R, Jolesz FA, Weiner HL. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis. Neurology. 1999;53:758-764.
13. Khoury SJ, Guttmann CR, Orav EJ, Kikinis R, Jolesz FA, Weiner HL. Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. Arch Neurol. 2000;57:1183-1189.